WO2022027941A1 - Implant et ensemble utilisé pour le former - Google Patents

Implant et ensemble utilisé pour le former Download PDF

Info

Publication number
WO2022027941A1
WO2022027941A1 PCT/CN2021/074686 CN2021074686W WO2022027941A1 WO 2022027941 A1 WO2022027941 A1 WO 2022027941A1 CN 2021074686 W CN2021074686 W CN 2021074686W WO 2022027941 A1 WO2022027941 A1 WO 2022027941A1
Authority
WO
WIPO (PCT)
Prior art keywords
artificial
guide wire
wire
channel
implant
Prior art date
Application number
PCT/CN2021/074686
Other languages
English (en)
Chinese (zh)
Inventor
郭扬
Original Assignee
上海端佑医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN202010769208.5A external-priority patent/CN114052986A/zh
Priority claimed from CN202021581035.6U external-priority patent/CN212730074U/zh
Application filed by 上海端佑医疗科技有限公司 filed Critical 上海端佑医疗科技有限公司
Publication of WO2022027941A1 publication Critical patent/WO2022027941A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body

Definitions

  • the present invention relates to the field of medical devices, in particular to an implant and an assembly for forming the implant.
  • the mitral valve is a complex tissue structure between the left atrium (LA) and the left ventricle (LV), consisting of the mitral valve annulus, anterior mitral valve leaflets, posterior mitral valve leaflets, mitral valve chordae tendineae and papillary muscles composition.
  • the mitral valve ensures that blood can only flow from the left atrium to the left ventricle, not the reverse.
  • a normal healthy mitral valve has multiple chordae tendineae, one end of which connects to the leaflet edge and one end to the papillary muscle located in the ventricular wall.
  • the anterior and posterior leaflets of the mitral valve When the left ventricle is in diastole, the anterior and posterior leaflets of the mitral valve are opened, the chordae tendineae are in a relaxed state, and blood flows from the left atrium to the left ventricle; when the left ventricle is in the systolic phase, the anterior and posterior leaflets of the mitral valve are in opposition under the action of blood pressure, and at the same time Due to the pulling effect of the chordae tendineae, the valve leaflets will not be turned over to the atrial side due to blood pressure. Under the combined action of the valve leaflets and the chordae tendineae, the blood flow channel between LA and LV is closed, and blood can only pass through the left ventricle.
  • the aortic valve (AV for short) flows into the aorta and sends it to various organs throughout the body.
  • AV aortic valve
  • chordae tendineae or papillary muscles have lesions, or are impacted by external forces, part of the chordae tendineae is often elongated or ruptured.
  • the left ventricle contracts, the valve leaflets are turned over to the side of the atrium due to the loss of chordae tendineae traction under the action of blood pressure. , causing the valve leaflets to fail to close tightly, resulting in blood regurgitation, that is, mitral regurgitation.
  • chordae tendineae rupture produces mild-to-moderate mitral regurgitation
  • the patient will not experience immediate clinical symptoms due to the compensatory function of the heart, but increased tension of other chordae tendineae will produce new chordae tendineae ruptures, and left atrial pressure rises High, will lead to the gradual expansion of the left atrium and mitral valve annulus, aggravate the degree of regurgitation, increase left ventricular preload, lead to left ventricular dilatation and systolic dysfunction, and then lead to left heart failure, and often lead to global heart failure, severe Endanger the patient's life and health.
  • chordae tendineae of the mitral valve Even if a few chordae tendineae are ruptured, the tension of other chordae tendineae can be increased and new chordae tendineae rupture can occur. It can be seen that the elongation or rupture of the chordae tendineae of the mitral valve has a great impact on human health and requires clinical intervention.
  • Mitral regurgitation due to lesions of the chordae tendineae or rupture of the chordae tendineae can usually be treated with drugs, surgery, or interventional procedures.
  • Drug methods such as antihypertensive, diuretic, etc.
  • cardiac surgery is still the gold standard for clinical treatment.
  • Cardiac surgery requires general anesthesia and thoracotomy, with the help of cardiopulmonary bypass to perform direct-view operation under the condition of cardiac arrest. The operation process is complicated, the risk of patient trauma and complications is high, and the hospitalization recovery time is long. It is not suitable for low cardiac function, many complications, Elderly and other high-risk surgical patients.
  • the interventional artificial chord repair device generally includes a delivery system and an implant.
  • the implant includes an artificial chord, a leaflet anchoring element and a papillary muscle anchoring element.
  • the artificial chord prosthesis enters the heart from the delivery system.
  • the leaflet anchoring elements connect the valve leaflets, and the papillary muscle anchoring elements connect the papillary muscles, thereby replacing the elongated or ruptured native chordae tendineae, eliminating or reducing mitral regurgitation.
  • the artificial chordae tendineae can be effectively treated only when they are firmly and reliably connected with the valve leaflets and papillary muscles. Because the papillary muscle belongs to the trabecular system of the ventricular muscle, the structure is relatively thick and dense, and the existing fixation methods of various interventional instruments in the ventricle (such as screw screwing, barb anchoring, etc.) can ensure firm anchoring.
  • the connection technology of artificial chordae tendineae and valve leaflets is more difficult to realize, mainly reflected in two aspects: First, the fixation reliability.
  • the material of the artificial chordae tendineae is currently polytetrafluoroethylene (PTFE) or expanded polytetrafluoroethylene (EPTFE).
  • knot; two leaflet tear.
  • PTFE polytetrafluoroethylene
  • EPTFE expanded polytetrafluoroethylene
  • the mitral valve leaflets are composed of a cavernous atrial layer and a fibrous ventricular layer, with a thickness of 1-4 mm, the strength is low, and a large local stress is generated under the pulling action of the chordae tendineae, which can easily lead to tearing of the valve leaflets, thereby causing the artificial chordae tendineae to fall off and lose the therapeutic effect.
  • the main methods of leaflet anchoring are metal anchor claw, wire knot and spacer fixing.
  • Cardiomech designed a metal anchor, which has a high surgical risk.
  • the wound caused by the anchor claw puncturing and grasping the valve leaflet is large, which is likely to cause acute perforation of the valve leaflet.
  • an object of the present invention is to provide an implant and an assembly for forming the implant to solve the problems in the prior art.
  • a first aspect of the present application provides an implant, the implant includes an artificial chordae tendineae and a papillary muscle anchoring element, the artificial chordae tendineae includes an artificial chordae tendineae body and a The anchoring valve leaflet at one end of the artificial chord body uses a self-tightening structure, and the other end of the artificial chord body is connected with the papillary muscle anchoring element.
  • the self-tightening structure for anchoring valve leaflets includes a self-tightening wire knot and a valve leaflet anchoring ring, and the valve leaflet anchoring ring is closed and locked at the self-tightening wire knot.
  • the self-tightening knot is selected from the group consisting of Bollinger knots, rope end knots, double bar knots, and flat knots.
  • the implant further includes a spacer through which the leaflet anchoring ring extends.
  • the spacer includes a first spacer and/or a second spacer, and the leaflet anchoring ring is matched with the first spacer and/or the second spacer and is locked by the self-tightening knot to form a valve Leaf anchoring structure.
  • the papillary muscle anchoring element is in a spiral shape, a barb-shaped column or a ship-anchor-like shape.
  • a second aspect of the present invention provides an assembly for forming the implant, the assembly including an artificial chord body and a papillary muscle anchoring element, the artificial chord body including a connecting segment for guiding, an artificial chord
  • the body segment and the wire segment for forming a self-tightening structure, the artificial tendon cable body is suitable for forming the artificial tendon cable in the implant, and optionally, the assembly further includes a spacer.
  • the free end of the connecting section for guiding is provided with a magnetic block, a tenon-and-mortise structure or a snap-fit structure; preferably, the connecting section for guiding can be removed by shearing.
  • the artificial tendon cable body is selected from wires.
  • a third aspect of the present invention provides an interventional artificial chord repair device, the repair device includes the component, a connecting guide wire and a delivery system, the connecting guide wire is provided in the delivery system, and the delivery system is provided with an adaptor The channel of the artificial tendon cord body in the assembly.
  • the connecting guide wire is selected from metal wires. Further, when the interventional artificial chordae tendineae repair device is implanted, the connecting guide wire and the guiding connecting segment are detachably connected.
  • the delivery system includes a first chuck and a second chuck, the first chuck is provided with a U-shaped channel, the second chuck is provided with a central channel, a first side wall channel and a second side wall channel, the One end of the first side wall channel and one end of the second side wall channel are both communicated with the central channel.
  • the other end of the first side wall channel and the other end of the second side wall channel are respectively aligned with the two openings of the U-shaped channel.
  • the interventional artificial chord repair device further comprises an auxiliary connecting guide wire and an auxiliary connecting wire
  • the auxiliary connecting guide wire is detachably connected to the connecting section for guiding
  • the auxiliary connecting wire is arranged in the U-shaped channel, and one end of the auxiliary connecting wire is detachable. It is detachably connected with the guiding connecting segment and/or the auxiliary connecting guide wire, and the other end is detachably connected with the connecting guide wire.
  • a fourth aspect of the present invention provides a method for forming the implant, the forming method comprising the steps of:
  • the artificial chordae tendineae body and the papillary muscle anchoring element are movably connected, the length of the artificial chord chordae body is adjusted, the connecting section for guiding is cut off, and the artificial chordae tendineae body and the papillary muscle anchoring element are fixedly connected to form an implant.
  • a fifth aspect of the present invention provides the use of the implant, the component or the interventional artificial chordae tendineae repair device in preparing a product for treating mitral valve regurgitation.
  • the implant, the assembly and the interventional artificial chord repair device of the present invention have the following beneficial effects:
  • Metal-free implantation can be achieved without causing metal allergy or immune response.
  • the self-tightening knot is different from the movable knot in the way of anchoring the valve leaflet. After the self-tightening knot is fixed, there will be no displacement, which reduces the friction between the knot and the valve leaflet.
  • the anchoring wound is small, and the original valve leaflet is damaged. Small, not easy to produce leaflet tear, firm fixation, good anchoring effect, and stable regurgitation treatment effect; at the same time, the self-tightening knot has less damage to the native valve leaflet than the metal anchor claw, which is conducive to the rapid endothelialization of the implant, Endothelialization is better and does not change the anatomical shape of the valve leaflets.
  • Figure 1 shows a schematic diagram of the implant of the present application.
  • Figure 2 shows a schematic diagram of four kinds of self-tightening thread knots of the present application, which are double bar knot (Figure 2a), rope end knot (Figure 2b), flat knot (Figure 2c), and Bollinger knot (Figure 2d).
  • Figure 3 is a schematic diagram showing the structure of three kinds of papillary muscle anchoring elements according to the present application, which are a spiral structure (Figure 3a), a barbed structure (Figure 3b), and a ship-anchor-like structure (Figure 3c).
  • FIG. 4 shows a schematic diagram of the interventional artificial chordae tendineae repair device of the present application.
  • FIG. 5 is a schematic diagram showing the steps of using the interventional artificial chordae tendineae repair device of the present application.
  • FIG. 6 shows another schematic diagram of the interventional artificial chord repair device of the present application.
  • FIG. 7 is a schematic diagram showing the steps of using the interventional artificial chord repair device of FIG. 6 .
  • FIG. 8 is a schematic diagram showing the steps of using the interventional artificial chordae tendineae repair device of the present application.
  • a first aspect of the present application provides an implant, the implant includes an artificial chord 1 and a papillary muscle anchoring element 2 , and the artificial chord 1 includes an artificial chord body 11 and a The self-tightening structure 12 is used for the anchoring leaflet at one end of the artificial chord body 11 , and the other end of the artificial chord body 11 is connected to the papillary muscle anchoring element 2 .
  • the self-tightening structure 12 for anchoring the leaflet includes a self-tightening wire knot 121 and a leaflet anchoring ring 122, and the leaflet anchoring ring 122 is closed and locked at the self-tightening wire knot.
  • the self-tightening wire knot 121 is a wire knot that can be locked when one end of the wire end is tightened.
  • the self-tightening thread knot 121 is selected from the group consisting of double bar knot (FIG. 2a), rope knot (FIG. 2b), flat knot (FIG. 2c), and Bollinger knot (FIG. 2d).
  • the self-tightening knot 121 is preferably a rope knot.
  • the rope knot knotting method is simple, fast and easy to implement.
  • the self-tightening knot 121 realizes that the knot can be locked when one end of the thread is tightened through different winding methods of the suture.
  • the self-tightening knot 121 and the leaflet anchoring ring 122 can be an integral structure with the artificial chord body 11, or can be three independent structures connected, or can be the artificial chord body 11 and the leaflet anchoring ring 122.
  • the self-tightening knot is a knot for locking the leaflet anchoring ring 122 with separate sutures.
  • the self-tightening wire knot 121 and the leaflet anchoring ring 122 and the artificial chord body 11 are integral structures.
  • the artificial chordae 1 is wound into a knot by itself to avoid using too many sutures in the body, and at the same time, it is easy to control, avoid the loosening of the knot, and can also improve the operation speed.
  • the implant further includes a spacer, and the leaflet anchoring ring 122 penetrates the spacer 3 .
  • the spacer 3 includes a first spacer 31 and/or a second spacer 32, the leaflet anchoring ring 122 and the first spacer 31 and/or the second spacer 32
  • the valve leaflet anchoring structure is formed by matching and locking through the self-tightening wire knot 121 .
  • the first gasket 31 is a thin sheet structure.
  • the thickness of the first gasket 31 is 0.1-2 mm, preferably 0.3-1 mm.
  • the shape of the first gasket 31 can be selected from polygonal, circular, oval, preferably quadrilateral and oval.
  • the length of the quadrilateral is 1-10 mm, preferably 2-4 mm, and the width is 1-4 mm, preferably 1-2 mm.
  • the shape of the first gasket 31 is an ellipse, the long axis of the ellipse is 1-10 mm, preferably 2-4 mm, and the short axis is 1-4 mm, preferably 1-2 mm.
  • the second gasket 32 is a thin sheet structure.
  • the thickness of the second gasket 32 is 0.1-2 mm, preferably 0.3-1 mm.
  • the shape of the second gasket 32 may be polygonal, circular or oval, preferably quadrilateral or oval.
  • the quadrilateral length is 1-10mm, preferably 2-4mm, and the width is 1-4mm, preferably 1-2mm.
  • the shape of the second gasket 32 is an ellipse, the long axis of the ellipse is 1-10 mm, preferably 2-4 mm, and the short axis is 1-4 mm, preferably 1-2 mm.
  • the materials of the first gasket 31 and the second gasket 32 can be selected from polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (EPTFE), polyethylene terephthalate (PET), polyester, felt, Mesh wire weaving, etc.
  • the material of the first gasket 31 is preferably expanded polytetrafluoroethylene and polyethylene terephthalate.
  • first gasket 31 and the second gasket 32 may be the same or different, and the two may be used alone or in combination.
  • the first washer 31 and the second washer 32 play the roles of reducing the local traction stress of the valve leaflet, accelerating endothelialization, and increasing the anchoring stability.
  • the papillary muscle anchoring element 2 is selected from the group consisting of helix (Fig. 3a), barb (Fig. 3b), and anchor-like structure (Fig. 3c).
  • the papillary muscle anchoring element 2 can be embedded in myocardial tissue as a fixing mechanism for connecting the artificial chordae tendineae 1 with the myocardium.
  • a second aspect of the present invention provides an assembly for forming the implant, the assembly including an artificial chord body and a papillary muscle anchoring element 2, the artificial chord body including a connecting segment for guiding, an artificial tendon A cable body segment and a wire segment for forming a self-tightening structure, the artificial tendon cable body is suitable for forming the artificial tendon cable 1 in the implant.
  • the assembly further includes a gasket, and the leaflet anchoring ring 122 penetrates the gasket 3 .
  • the gasket 3 includes a first gasket 31 and a second gasket 32, and the leaflet anchoring ring 122 is matched with the first gasket 31 and the second gasket 32 and passed through the The self-tightening knot 121 is locked to form a leaflet anchoring structure.
  • the artificial tendon cable body is selected from wires. Specifically, the wire meets the requirements of the YY 0167-2020 standard.
  • the diameter specifications of the wire can be selected from 5-0, 4-0, 3-0, 2-0/T, and 2-0.
  • the diameter of the wire is preferably 3-0, 2-0.
  • Clinical data show that 3-0 and 2-0 diameter wires are closer to the needs of the chordae tendineae.
  • the structure of the wire can be single or multiple braided.
  • the structure of the wire is preferably a single strand. Single strands are more stable in structure, and multiple strands run the risk of snagging, twisting or twisting.
  • the material of the wire can be selected from polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (EPTFE), polyethylene terephthalate (PET), ultra-high molecular weight polyethylene (UHMWPE), mulberry silk, Nylon, cotton, etc.
  • the material of the wire rod is preferably polytetrafluoroethylene (PTFE) or expanded polytetrafluoroethylene (EPTFE).
  • PTFE polytetrafluoroethylene
  • EPTFE expanded polytetrafluoroethylene
  • EPTFE expanded polytetrafluoroethylene
  • the guiding connecting segment is used to assist in guiding the movement of the artificial chord body segment and the line segment for forming the self-tightening structure during transportation.
  • the connecting section for guiding can realize development under DSA, and you can choose to add developer to the connecting section for guiding, or wrap the developing wire, or the detachable connecting piece is made of developable materials, such as gold, platinum, PtW alloy, Tantalum or PtIr alloy, etc.
  • developable materials such as gold, platinum, PtW alloy, Tantalum or PtIr alloy, etc.
  • the line segment for forming the self-tightening structure corresponds to the line segment for forming the self-tightening structure 12 for anchoring the leaflet in the implant, while the main segment of the artificial chordae tendineae Then it corresponds to the line segment in the implant as the body of the artificial chordae tendineae.
  • the guiding connecting section, the artificial tendon body section and the self-tightening structure forming line can be different sections of one wire, three wires, or two wires.
  • the guiding connecting section and the artificial tendon are
  • the body segment is a wire
  • the wire segment for forming the self-tightening structure is another wire.
  • other combinations are possible as long as the implant can be formed.
  • the papillary muscle anchoring element 2 is selected from the group consisting of helix (Fig. 3a), barb (Fig. 3b), and anchor-like structure (Fig. 3c).
  • the papillary muscle anchoring element 2 can be embedded in myocardial tissue as a fixing mechanism for connecting the artificial chordae tendineae 1 with the myocardium.
  • a third aspect of the present invention provides an interventional artificial chord repair device, the repair device includes an implant, a connecting guide wire 41 and a delivery system 5 , and the connecting guide wire 41 is provided in the delivery system 5 .
  • the delivery system 5 is provided with a channel adapted to the artificial tendon cord body in the assembly.
  • the connecting guide wire 41 is selected from metal wires. Preferably, it is selected from metal wires that are elastic and have good supporting properties.
  • the diameter of the connecting guide wire 41 is 0.2-1.5 mm, preferably 0.5-1.0 mm.
  • the structure of the connecting guide wire 41 can be a single strand, a mandrel plus inner and outer springs, etc., preferably a single strand.
  • the material of the metal wire can be selected from nickel-titanium alloy, stainless steel, titanium alloy, preferably nickel-titanium alloy.
  • the head end of the connecting guide wire 41 is in the shape of a sharp needle.
  • the connecting guide wire 41 is detachably connected to the free end of the connecting segment for guiding.
  • the detachable connection method may be a snap, magnetic attraction, tenon and tenon, coupling, etc., which is not limited in the present invention.
  • the delivery system 5 includes a first chuck 51 and a second chuck 52 , the first chuck 51 is provided with a U-shaped channel 511 , and the second chuck 52 is provided with a central channel 521 , the first side wall channel 522 and the second side wall channel 523, one end of the first side wall channel 522 and one end of the second side wall channel 523 are communicated with the central channel 521.
  • the first side wall channel 522 is another One end and the other end of the second sidewall channel 523 are aligned with the two openings of the U-shaped channel 511 respectively.
  • the first chuck 51 and the second chuck 52 are respectively set at the same position on both sides of the leaflet 6 , that is, the first chuck 51 and the second chuck 52 can be aligned with the leaflet 6 apart.
  • first chuck 51 and the second chuck 52 can move relative to each other, and when they are close to each other, they clamp the valve leaflet.
  • the connecting guide The wire 41 can enter the U-shaped channel 511 after passing through the second gasket 32 , the valve leaflet 6 , and the first gasket 31 .
  • the first gasket 31 is pre-placed between the U-shaped channel 511 and the valve leaflet in the first collet 51
  • the second gasket 32 is pre-placed in the center of the second collet 52 .
  • the connecting guide wire 41 is pre-placed in the central channel 521; the preset connecting guide wire 41 is obliquely inserted into the first side wall channel 522; the self-tightening wire knot 121 is wound on the connecting guide wire 41, and the connecting segment is placed in the second side wall channel 523.
  • the interventional artificial chordae repair device is used to form the implant.
  • the method for forming the implant includes the following steps:
  • a part of the artificial tendon cable body is wound around the connecting guide wire 41; when the first collet 51 and the second collet 52 are clamped, the opening of the first side wall channel 522 and the second side wall channel 523 After the openings of the valve are aligned with the two openings of the U-shaped channel 511, the connecting guide wire 41 is pushed in the direction of the arrow shown in the figure to penetrate the second gasket 32, the valve leaflet 6, the first gasket 31 in turn, and enter the U-shaped channel 511;
  • the connecting guide wire 41 is withdrawn in the direction of the arrow shown in the figure, and the connecting guide wire 41 will drive the connecting section for guiding, the main body section of the artificial chordae tendineae, and the line section for forming the self-tightening structure to pass through the second gasket 32, After the valve leaflet 6 and the first gasket 31, the self-tightening structure forming line segment is closed at the self-tightening wire knot to form the valve leaflet anchoring ring 122;
  • the interventional artificial chord repair device further includes an auxiliary connecting guide wire 42 and an auxiliary connecting wire 43 , and the auxiliary connecting guide wire 42 is detachably connected to the connecting segment for guiding.
  • the auxiliary connecting wire 43 is arranged in the U-shaped channel 511 , one end is detachably connected to the guiding connecting section and/or the auxiliary connecting wire 42 , and the other end is detachably connected to the connecting wire 41 .
  • the setting of the auxiliary connecting guide wire 42 and the auxiliary connecting wire 43 can complete the implantation more quickly.
  • the detachable connection is selected from snap, magnetic attraction, tenon and tenon, coupling and the like.
  • the function of the auxiliary connection guide wire 42 is to guide the wire segment for forming the self-tightening structure and the main body segment of the artificial chordae tendineae into the U-shaped channel 511 through the guiding connection segment connected at one end.
  • the auxiliary connecting wire 43 includes a first connecting end 431 and a second connecting end 432 .
  • the first connecting end 431 is connected to the connecting guide wire 41
  • the second connecting end 432 is connected to the auxiliary connecting guide wire 42 . connected at one end.
  • the connection between the first connection end 431 and the connection guide wire 41 and the connection between the second connection end 432 and the auxiliary connection guide wire 42 are all detachable connections.
  • the function of the auxiliary connecting wire 43 is to help the connecting guide wire 41 to realize the connection with the connecting segment for guiding.
  • the auxiliary connecting wire 43 is detachably connected with the guiding connecting section.
  • the detachable connection is selected from snap, magnetic attraction, tenon and tenon, coupling and the like.
  • the auxiliary connecting wire 43 can realize development under DSA, and a developer can be added to the auxiliary connecting wire 43, or a metal wire can be wound, or the connection structure at both ends of the auxiliary connecting wire 43 can be made of metal material.
  • the connecting guide wire 41 and the auxiliary connecting guide wire 42 are preset in the central channel 521 ; the auxiliary connecting wire 43 is preset in the U-shaped channel 511 .
  • the method for forming the implant includes the following steps:
  • part of the artificial tendon cable body is wound around the connecting guide wire 41; when the first chuck 51 and the second chuck 52 are clamped, the opening of the first side wall channel 522, the second side wall After the openings of the channel 523 are respectively aligned with the two openings of the U-shaped channel 511, push the connecting guide wire 41 into the U-shaped channel 511 in the direction of the arrow shown in the figure and then connect with the second connection end 432; at the same time, push the auxiliary wire 41 in the direction of the arrow in the figure.
  • the connecting guide wire 42 enters the U-shaped channel 511 and is connected to the first connecting end 431 .
  • the guiding connecting section is carried by the auxiliary connecting guide wire 42 and enters the U-shaped channel 511 to connect with the first connecting end 431 .
  • the connecting guide wire 41 and the auxiliary connecting guide wire 42 both penetrate the second gasket 32 , the valve leaflet 6 , and the first gasket 31 in sequence and then enter the U-shaped channel 511 .
  • the auxiliary connection guide wire 42 is withdrawn in the direction of the arrow shown in the figure. After the auxiliary connection guide wire 42 is withdrawn, it is no longer used. At the same time, the connection guide wire 41 is withdrawn, and the connection guide wire 41 drives the auxiliary connection wire 43 to move.
  • the auxiliary connecting wire 43 drives the guiding connecting section, the artificial chordae body section, and the self-tightening structure forming section to move, and the self-tightening structure forming section closes the loop at the self-tightening knot to form the leaflet anchoring ring 122 .
  • the auxiliary connecting wire 43 drives the connecting segment for guiding, the body segment of the artificial chordae tendineae, and the segment for forming the self-tightening structure to move through the first gasket 31 , the valve leaflet 6 , and the second gasket 32 in sequence.
  • a fourth aspect of the present application provides the use of the implant, the assembly or the interventional artificial chordae tendineae repair device in the manufacture of a product for treating mitral valve regurgitation.
  • the steps of using the interventional artificial chordae tendineae repair device are as follows: the delivery system 5 enters the atrium from the atrial septum through the universal sheath ( FIG. 8 a ); Complete valve leaflet clamping with assistance (Figure 8b); release gasket 3 and valve leaflet with self-tightening structure 12, pull back delivery system 5, and withdraw artificial chordae tendineae 1 ( Figure 8c); use delivery system 5 to anchor papillary muscle Element 2 is anchored in the myocardium of the left ventricle (Fig. 8d); the delivery system 5 is withdrawn.
  • the papillary muscle anchoring element 2 is connected to one end of the connecting segment for guidance, and the length of the artificial chordae tendineae is adjusted by ultrasound imaging to ensure no reflux (Fig. 8e). After adjusting the length, cut off the connecting segment for guiding, and the final state of the implant in the heart is shown in Fig. 8f.
  • the use of the implant or the interventional artificial chordae tendineae repair device can complete the fixation of the artificial chordae tendineae and valve leaflets through an interventional manner, without the need for thoracotomy, with less surgical trauma and quicker recovery of the patient. And the fixation is firm, the valve leaflet is not easily torn, and at the same time, it is conducive to the rapid endothelialization of the implant and the healing of the wound surface.
  • the present invention effectively overcomes various shortcomings in the prior art and has high industrial utilization value.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

La présente invention concerne un implant et un ensemble utilisé pour le former. L'implant comprend un chordae tendineae artificiel (1) et un élément d'ancrage de muscle papillaire (2). Le chordae tendineae artificiel (1) comprend un corps de chordae tendineae artificiel (11) et une structure auto-serrante (12) formée sur une extrémité du corps de chordae tendineae artificiel (11) et utilisée pour ancrer un feuillet. L'autre extrémité du corps de chordae tendineae artificiel (11) est reliée à l'élément d'ancrage de muscle papillaire (2). L'implant optimise un moyen de sécurisation de feuillet de la prothèse de chordae tendineae artificiel, achevant la fixation solide du chordae tendineae artificiel au feuillet à l'aide de la chirurgie d'intervention, et l'ouverture de la poitrine est inutile, le traumatisme chirurgical est faible, et la récupération du patient est rapide ; un nœud fileté auto-serrant n'est pas déplacé, ce qui réduit la friction entre le nœud fileté et le feuillet, la surface de lésion de l'ancrage est petite, il existe peu de détérioration au feuillet natif, l'effet d'ancrage est bon, et l'effet de reflux du traitement est stable ; de manière additionnelle, l'endothélialisation rapide de l'implant est facilitée, les résultats d'endothélialisation sont meilleurs, et la forme anatomique du feuillet ne sera pas modifiée.
PCT/CN2021/074686 2020-08-03 2021-02-01 Implant et ensemble utilisé pour le former WO2022027941A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN202010769208.5A CN114052986A (zh) 2020-08-03 2020-08-03 一种植入物及用于形成植入物的组件
CN202010769208.5 2020-08-03
CN202021581035.6 2020-08-03
CN202021581035.6U CN212730074U (zh) 2020-08-03 2020-08-03 一种植入物及用于形成植入物的组件和介入人工腱索修复装置

Publications (1)

Publication Number Publication Date
WO2022027941A1 true WO2022027941A1 (fr) 2022-02-10

Family

ID=80116901

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/074686 WO2022027941A1 (fr) 2020-08-03 2021-02-01 Implant et ensemble utilisé pour le former

Country Status (1)

Country Link
WO (1) WO2022027941A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115634076A (zh) * 2022-10-08 2023-01-24 瀚芯医疗科技(深圳)有限公司 人工腱索夹持装置以及操作器

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101902975A (zh) * 2007-10-18 2010-12-01 尼奥绰德有限公司 搏动心脏中瓣膜小叶的微创修复
WO2013003228A1 (fr) * 2011-06-27 2013-01-03 University Of Maryland, Baltimore Dispositif de réparation par voie apicale de valvule mitrale
CN103889345A (zh) * 2011-04-15 2014-06-25 心脏缝合有限公司 用于缝合解剖学瓣的缝合装置和方法
CN104248457A (zh) * 2014-09-03 2014-12-31 郭文彬 一种人工腱索装置、穿引元件及套件
US20170258464A1 (en) * 2014-01-03 2017-09-14 Harpoon Medical, Inc. Method and apparatus for transapical procedures on a mitral valve
CN108697418A (zh) * 2015-11-02 2018-10-23 马里兰大学巴尔的摩分校 用于二尖瓣瓣膜修复的远侧锚固设备和方法
US20190380705A1 (en) * 2015-10-02 2019-12-19 Ceterix Orthopaedics, Inc. Knot tying accessory
CN110650710A (zh) * 2017-04-06 2020-01-03 哈珀恩医疗有限公司 用于二尖瓣修复的远侧锚固件器械和方法
CN111467081A (zh) * 2020-03-30 2020-07-31 科凯(南通)生命科学有限公司 一种多点固定式人工腱索植入装置

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101902975A (zh) * 2007-10-18 2010-12-01 尼奥绰德有限公司 搏动心脏中瓣膜小叶的微创修复
CN103889345A (zh) * 2011-04-15 2014-06-25 心脏缝合有限公司 用于缝合解剖学瓣的缝合装置和方法
WO2013003228A1 (fr) * 2011-06-27 2013-01-03 University Of Maryland, Baltimore Dispositif de réparation par voie apicale de valvule mitrale
US20170258464A1 (en) * 2014-01-03 2017-09-14 Harpoon Medical, Inc. Method and apparatus for transapical procedures on a mitral valve
CN104248457A (zh) * 2014-09-03 2014-12-31 郭文彬 一种人工腱索装置、穿引元件及套件
US20190380705A1 (en) * 2015-10-02 2019-12-19 Ceterix Orthopaedics, Inc. Knot tying accessory
CN108697418A (zh) * 2015-11-02 2018-10-23 马里兰大学巴尔的摩分校 用于二尖瓣瓣膜修复的远侧锚固设备和方法
CN110650710A (zh) * 2017-04-06 2020-01-03 哈珀恩医疗有限公司 用于二尖瓣修复的远侧锚固件器械和方法
CN111467081A (zh) * 2020-03-30 2020-07-31 科凯(南通)生命科学有限公司 一种多点固定式人工腱索植入装置

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115634076A (zh) * 2022-10-08 2023-01-24 瀚芯医疗科技(深圳)有限公司 人工腱索夹持装置以及操作器
CN115634076B (zh) * 2022-10-08 2023-09-01 瀚芯医疗科技(深圳)有限公司 人工腱索夹持装置以及操作器

Similar Documents

Publication Publication Date Title
US11622759B2 (en) Systems and methods for anchoring an implant
US11744573B2 (en) Devices and methods for locating and implanting tissue anchors at mitral valve commissure
US20220354648A1 (en) Device, system, and method for transcatheter treatment of valve regurgitation
CN110913772B (zh) 用于重塑心脏瓣膜环的递送系统和方法，包括使用磁性工具
US10172621B2 (en) Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
JP5371440B2 (ja) 乳頭筋位置制御装置、システム及び方法
US20060106278A1 (en) Devices, systems, and methods for reshaping a heart valve annulus, including the use of an adjustable bridge implant system
US20080288060A1 (en) Treating Valvular Insufficiency
JP2003521310A (ja) 経皮僧帽弁環状形成及び心臓補強
SE531468C2 (sv) En anordning för styrning av blodflöde
CA2877344A1 (fr) Dispositif, systeme et procede pour le traitement, par transcatheter, d'une regurgitation de valvule
CN109498216A (zh) 一种用于瓣膜修复的牵拉线锁定导管
JP2008534084A (ja) 心臓弁輪を再形成するための装置、システム、および方法
WO2022027941A1 (fr) Implant et ensemble utilisé pour le former
Buchanan et al. Circumferential suture of the mitral annulus for correction of mitral regurgitation in dogs
CN113827285A (zh) 组织缺损的闭合器械
WO2023040272A1 (fr) Instrument de fermeture de défaut tissulaire
CN111374800A (zh) 一种瓣膜缩环系统
CN212730074U (zh) 一种植入物及用于形成植入物的组件和介入人工腱索修复装置
WO2020134053A1 (fr) Système de retrait d'anneau de valve
WO2020134052A1 (fr) Système de réduction d'anneau de valvule guidé par une fenêtre unique
CN114052986A (zh) 一种植入物及用于形成植入物的组件
CN216702724U (zh) 一种瓣叶锚固件及人工腱索修复装置
CN209966663U (zh) 一种瓣膜缩环系统
CN216777122U (zh) 组织缺损的闭合器械

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21854285

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21854285

Country of ref document: EP

Kind code of ref document: A1